CHICAGO, March 23, 2011 /PRNewswire/ -- Available at ICAP Ocean Tomo's Spring 2011 Live IP Auction, this patent portfolio discloses methods and techniques related to patch-based drug delivery and monitoring.
Administering drugs orally or by injection each has inherent problems. Orally administered drugs (e.g., tablets or pills) pass through the patient's digestive system which breaks down the drug into its constituting components and flushes the rest of the compound out of the body. Consequently, only a small percentage of the administered medicine enters the patient's circulatory system, limiting the drug's effectiveness. This also means that a relatively large intake of medicine is required for effective treatment. Yet, a large dose may adversely affect the patient's digestive system. This can cause many anomalies and harmful side effects.
Drug delivery by injection can be more effective. However, conventional injections may cause pain, require close medical supervision, and add the potential risk of infections. Furthermore, injected medicines cannot be controlled or withdrawn from the body if any adverse effects are observed. In the case of animals, these drug delivery techniques are often risky due to possible aggressive reflex actions during administration of the drug. For these reasons, a safe, controlled and effective alternative method using a transmucosal patch has inherent advantages.
Key Characteristics & Benefits
This patent lot discloses the following:
- Advanced techniques for delivering drugs through mucosal surface or body tissues of a patient (i.e. human or animal), such as the mouth.
- This transmucosal drug delivery technique utilize